🔗 Share this article

An underground market for unapproved slimming medications is propelled by social media fitness personalities and sellers on communication apps, based on new investigations.

Investigational Drug Gaining Traction Online

Retatrutide, which remains in clinical trials, is being promoted by online personalities for its alleged weight-reducing effects. Followers are encouraged to message these profiles privately for source information, while also obtaining discount codes.

Thriving Trade on Messaging Platforms

Additionally, a robust market exists on messaging services, where communities with thousands of participants share “before and after” photos, administration instructions and claims of next-day UK delivery. Vendors promote the substance there before redirecting buyers to other platforms for purchases.

Understanding Retatrutide

Retatrutide is an experimental injectable created by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could help patients lose up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being hailed online as the successor to Ozempic.

Healthcare Experts Express Worries

Nevertheless, physicians and chemists have cautions that the distribution of what remains an unlicensed medication in the United Kingdom is a cause for concern and could lead to individuals administering products of uncertain source.

Some experts said the popularity for retatrutide could be linked to the rising cost of licensed weight loss products such as Mounjaro.

Regulatory Status and Enforcement

Marketing retatrutide on social media or messaging apps is illegal in the United Kingdom, as it is an unlicensed medication that must not be marketed or supplied for human use under the British medical regulations.

Several influencers attempt to sidestep the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and distribution can still violate medicines, advertising, and customer laws, risking penalties, legal action or imprisonment.

Platform Reaction and Material Removal

According to TikTok, the service has taken down violative material and prohibited related keywords and query recommendations. The company stated it was dedicated to maintaining the service safe and allocating resources in enhancing compliance measures.

Digital Marketplace Operations

Investigations also discovered communities with up to nine thousand participants selling the experimental drug using Telegram's integrated discovery tool, which operates like a public directory. Typing “retatrutide” immediately brings up groups with thousands of members, filled with images of slimming results, positive reviews and step-by-step instructions for mixing or injecting at home.

After moments of entering one group, a vendor shared WhatsApp details, where most purchases take place. The seller sent an guidebook and promised shipping within 48 hours. When questioned whether the product was authentic, one vendor said: “You can’t be sure.” Another shared a photo of a supposed testing documentation. Not one inquired about weight, health issues or past usage.

Item Information and Pricing

Within these communities, posts display black plastic parcels with postal service stickers, claiming to include fresh supplies. One message read: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, mixed at home with sterile water, or pre-filled injectors typically sold at £160 for 20 milligrams. When questioned how long a pen should be used, sellers give contradictory answers varying between a few weeks to “depends on your body”.

Platform Moderation and Safety Measures

A representative for Telegram stated it regularly moderated dangerous content on its platform including content that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Medical Expert Cautions

“Individuals are injecting materials they cannot confirm. Even if the science behind retatrutide is valid, these online products may not include what they advertise,” stated Jason Murphy, the head of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of an online medical service linked the increase in demand to current price rises for authorized slimming medications such as Mounjaro. “With prices rising, individuals are turning to social media. But counterfeit injections are extremely dangerous. You cannot know what’s inside or whether the conditions they were produced in was sterile,” she explained.

Her team has previously seen patients injured by personal administration from unconfirmed suppliers. “We recognize the frustration, but purchasing from Telegram or WhatsApp is taking chances with your health,” stated Wyllie. “These materials could be impure or improperly measured.”

Producer Position

A spokesperson from Eli Lilly stated the substance was in phase 3 clinical trials and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Therefore at this time no one can sell [it] for personal consumption,” they said, noting that any item “falsely representing itself as a company experimental product not yet approved … may expose patients to possibly serious health risks”.